Managing Director or Director, Equity Research Analyst, Biotechnology Oncology

Bank of Montreal•New York, NY

13d•$275,000 - $350,000

About The Position

BMO Capital Markets is a leading, full-service North American-domiciled financial services provider offering equity and debt underwriting, corporate lending and project financing, merger and acquisitions advisory services, securitization, treasury management, market risk management, debt and equity research, and institutional sales and trading. BMO Capital Markets has approximately 2,700 professionals in 33 locations around the world. The Equity Research department covers close to 900 stocks across diverse sectors. Our healthcare research team is currently searching for a Senior Biotechnology Research Analyst to lead coverage of small and mid-cap oncology companies. Description The Senior Biotechnology Research Analyst is responsible for leading BMO’s coverage of small and mid-cap oncology companies across modalities and development stages. The individual serves as a trusted advisor to internal and external stakeholders. The ideal candidate can translate scientific analysis and clinical data into differentiated and actionable investment theses for buy-side clients and other key stakeholders. Experience/Skills This role combines deep industry expertise with strategic thinking to deliver actionable insights, innovative solutions, and a high-impact client experience. A combination of exceptional writing skills, technical knowledge and skills in equity research, finance/accounting, demonstrated through relevant work and educational experiences. Candidates must have a clear and proven track record of achievement throughout their education and career. Other key responsibilities and attributes include:

Requirements

10+ years of relevant experience (sell-side equity research, buy-side investing, or investment banking) and post-secondary degree (PhD, MD, PharmD, MS, or MBA)
U.S. Only: FINRA Series 7, 63, 86 & 87 licenses
Expertise in oncology and the biotechnology sector
Deep relationships across public and private oncology companies; in addition to key opinion leaders and expert physicians in oncology
Ability to assess viability, competitive positioning, and likelihood of success of pre-clinical and clinical-stage oncology assets
Strong financial modeling and valuation skills, with a focus on forecasting early- and mid-stage oncology companies
Exceptional written and oral communication skills; ability to present complex information to a variety of audiences (internal and external), with differing levels of industry knowledge and expertise (e.g., generalists sell-side sales professionals, buy-side sector-specific investors, and industry executives)
Recognized as a thought leader in oncology and the broader biotechnology sector; provides a unique and differentiated point of view to firm clients
Proven ability to lead a team and develop associate analysts

Nice To Haves

CFA certification is a plus, but not a requirement

Responsibilities

Lead coverage of small and mid-cap oncology companies, across modalities and developmental stages
Ideate and execute on production of differentiated and timely research; provide a unique point of view on the oncology and broader biotechnology sector
Build and maintain robust financial and probability-adjusted revenue/pipeline models for oncology companies
Present well supported investment recommendations for covered companies, including ratings and target prices
Ability to analyze clinical trial design and data across early and late-stage oncology trials (including dose escalation, dose-expansion, PFS/OS and response endpoints, statistical powering, and drug safety)
Deep understanding of the drug regulatory and reimbursement environment across geographies
Monitoring of the competitive landscape as it relates to covered companies
Host expert calls and events with oncologists and other specialists
Represent BMO and the Healthcare Research team at major oncology conferences (ASCO, ESMO, AACR, ASH)
Independently vet and assess companies for potential transactions underwritten by BMO’s investment bank, including IPOs and secondary equity raises
Form and maintain deep relationships across companies (public and private), investors, and other experts in and adjacent to the sector
Connect companies with investors via NDRs, BMO conferences, and other events
Acts as a trusted advisor to internal and external stakeholders
Drive buy-side investor votes and revenue
Acts in a leadership role to drive improved efficiency and effectiveness in the department and broader Capital Markets organization
Collaboration with other senior research analysts for cross-sector/ franchise research, events, and investor marketing
Partnership with sales and trading professionals within BMO, timely responses and action on client requests
Considers risk, internal controls and compliance as part of day-to-day accountabilities and adheres to policies and procedures
Operates at a group/enterprise-wide level and serves as a senior specialist resource across BMO